Skip to main content

Advertisement

Table 1 PROTECT Trial, post-hoc analysis of ITTIV population

From: Oral heparin: status review

ITTIV population N = 299 (includes all patients from USA, Canada/Australia) Low dose oral-heparin (60,000 IU/1.5 g SNAC) 30 days) High dose oral-heparin (90,000 IU/2.25 g SNAC) 30 days Injectable LOVENOX ® 30 mg s.c b.i.d.)10-day followed by placebo (to day 30)
Total DVT rate 27% 18% 28%
Relative Risk Reduction 4% 55%